Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis (Q44277349)

1 December 2017

title

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis (English)

1 reference

1 December 2017

0 references

0 references

cardiovascular disease

1 reference

Daniel G Hackam

1 reference

1 December 2017

Muhammad Mamdani

series ordinal

1 reference

1 December 2017

Ping Li

series ordinal

1 reference

1 December 2017

Donald A Redelmeier

series ordinal

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

1 December 2017

1 reference

inferred from page(s)

published in

The Lancet

1 reference

1 December 2017

volume

367

1 reference

1 December 2017

issue

9508

1 reference

1 December 2017

page(s)

413-418

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Current epidemiology of septic shock: the CUB-Réa Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Beyond the laboratory: clinical implications for statin pleiotropy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Prior statin therapy is associated with a decreased rate of severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

The effect of statins on mortality in patients with bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Drug-drug interactions among elderly patients hospitalized for drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Is sepsis accurately coded on hospital bills?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Epidemiology of sepsis in Victoria, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Risk of cataract in patients treated with statins.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Simvastatin blunts endotoxin-induced tissue factor in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Simvastatin prevents vascular hyporeactivity during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Statin treatment after onset of sepsis in a murine model improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Statins inhibit HIV-1 infection by down-regulating Rho activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968041-0

7 January 2021

10.1016/S0140-6736(06)68041-0

Identifiers

DOI

1 reference

1 December 2017

1 reference